Immobilized Fluorescent Human CD20 Full Length Protein-VLP (Cat. No. CDP-HF2P8) at 5 μg/mL (100 μL/well) can bind Rituximab biosimilar (Cat. No. CD0-M36) with a linear range of 0.2-3 μg/mL (QC tested).
Immobilized Fluorescent Human CD20 Full Length Protein-VLP (Cat. No. CDP-HF2P8) at 5 μg/mL (100 μL/well) can bind Rituximab with a linear range of 5-39 ng/mL (QC tested).
Immobilized Fluorescent Human CD20 Full Length Protein-VLP (Cat. No. CDP-HF2P8) at 5 μg/mL (100 μL/well) can bind Ofatumumab with a linear range of 1-20 ng/mL (QC tested).
Immobilized Fluorescent Human CD20 Full Length Protein-VLP (Cat. No. CDP-HF2P8) at 5 μg/mL (100 μL/well) can bind Ofatumumab with a linear range of 0.2-3 μg/mL (QC tested).
Supplier Page from ACROBiosystems for Fluorescent Human CD20 Full Length Protein (VLP)